Nifty
Sensex
:
:
17196.70
57696.46
-204.95 (-1.18%)
-764.83 (-1.31%)

Pharmaceuticals & Drugs - Global

Rating :
34/99

BSE: 532300 | NSE: WOCKPHARMA

440.95
03-Dec-2021
  • Open
  • High
  • Low
  • Previous Close
  •  432.90
  •  448.00
  •  431.40
  •  431.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  946180
  •  4175.33
  •  804.90
  •  393.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,888.07
  • N/A
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 6,928.01
  • N/A
  • 1.44

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.04%
  • 1.12%
  • 25.25%
  • FII
  • DII
  • Others
  • 2.88%
  • 0.02%
  • 2.69%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -4.44
  • -7.21
  • -12.75

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.64
  • 34.04
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.39
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.38
  • 1.84
  • 1.45

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 55.73
  • 79.62
  • 51.91

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Dec 20
Dec 19
Var%
Net Sales
862.00
714.05
20.72%
859.55
598.27
43.67%
631.96
686.93
-8.00%
764.02
748.60
2.06%
Expenses
766.17
697.35
9.87%
752.01
670.32
12.19%
712.22
680.92
4.60%
708.23
680.54
4.07%
EBITDA
95.83
16.70
473.83%
107.54
-72.05
-
-80.26
6.01
-
55.79
68.06
-18.03%
EBIDTM
11.12%
2.34%
12.51%
-12.04%
-12.70%
0.87%
7.30%
9.09%
Other Income
5.20
16.24
-67.98%
14.90
7.95
87.42%
21.74
21.17
2.69%
103.13
42.26
144.04%
Interest
69.06
60.90
13.40%
64.10
73.70
-13.03%
54.63
61.44
-11.08%
59.85
78.73
-23.98%
Depreciation
61.21
57.15
7.10%
64.34
55.96
14.97%
65.03
60.87
6.83%
67.88
56.22
20.74%
PBT
-29.24
-85.11
-
-6.00
-336.24
-
-178.18
-95.13
-
31.19
-24.63
-
Tax
-66.41
-88.40
-
0.58
-110.66
-
-71.34
-143.86
-
-1.21
-17.12
-
PAT
37.17
3.29
1,029.79%
-6.58
-225.58
-
-106.84
48.73
-
32.40
-7.51
-
PATM
4.31%
0.46%
-0.77%
-37.71%
-16.91%
7.09%
4.24%
-1.00%
EPS
3.03
0.32
846.88%
-1.15
68.63
-
-8.38
4.36
-
1.38
0.87
58.62%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
3,117.53
2,762.04
3,325.15
4,158.38
3,936.90
4,014.61
4,453.22
4,481.54
4,830.36
5,609.42
4,350.50
Net Sales Growth
13.45%
-16.93%
-20.04%
5.63%
-1.94%
-9.85%
-0.63%
-7.22%
-13.89%
28.94%
 
Cost Of Goods Sold
1,284.05
1,135.49
1,203.45
1,636.31
1,797.53
1,662.07
1,613.68
1,487.48
1,806.25
1,747.56
1,534.38
Gross Profit
1,833.48
1,626.55
2,121.70
2,522.07
2,139.37
2,352.54
2,839.54
2,994.06
3,024.11
3,861.86
2,816.12
GP Margin
58.81%
58.89%
63.81%
60.65%
54.34%
58.60%
63.76%
66.81%
62.61%
68.85%
64.73%
Total Expenditure
2,938.63
2,832.36
3,082.03
4,050.63
3,935.07
3,988.39
3,958.98
3,772.14
3,804.65
3,549.74
2,996.79
Power & Fuel Cost
-
82.37
85.41
93.30
77.80
110.10
113.99
101.40
92.17
97.08
80.38
% Of Sales
-
2.98%
2.57%
2.24%
1.98%
2.74%
2.56%
2.26%
1.91%
1.73%
1.85%
Employee Cost
-
762.95
743.33
800.38
937.06
966.51
950.77
868.87
768.63
655.90
572.91
% Of Sales
-
27.62%
22.35%
19.25%
23.80%
24.07%
21.35%
19.39%
15.91%
11.69%
13.17%
Manufacturing Exp.
-
151.85
120.90
153.76
135.27
179.40
228.07
236.03
240.85
180.06
115.03
% Of Sales
-
5.50%
3.64%
3.70%
3.44%
4.47%
5.12%
5.27%
4.99%
3.21%
2.64%
General & Admin Exp.
-
251.33
186.55
380.13
476.66
504.43
405.85
320.92
352.19
248.28
194.47
% Of Sales
-
9.10%
5.61%
9.14%
12.11%
12.56%
9.11%
7.16%
7.29%
4.43%
4.47%
Selling & Distn. Exp.
-
131.62
141.18
176.22
208.89
205.30
241.11
261.55
292.98
291.74
214.75
% Of Sales
-
4.77%
4.25%
4.24%
5.31%
5.11%
5.41%
5.84%
6.07%
5.20%
4.94%
Miscellaneous Exp.
-
316.75
601.21
810.53
301.86
360.58
405.51
495.89
251.58
329.12
214.75
% Of Sales
-
11.47%
18.08%
19.49%
7.67%
8.98%
9.11%
11.07%
5.21%
5.87%
6.55%
EBITDA
178.90
-70.32
243.12
107.75
1.83
26.22
494.24
709.40
1,025.71
2,059.68
1,353.71
EBITDA Margin
5.74%
-2.55%
7.31%
2.59%
0.05%
0.65%
11.10%
15.83%
21.23%
36.72%
31.12%
Other Income
144.97
153.43
60.08
21.02
120.23
100.83
66.10
66.55
38.40
54.00
25.34
Interest
247.64
249.08
275.74
265.14
255.49
225.27
128.96
55.21
83.35
215.37
269.02
Depreciation
258.46
246.02
224.14
163.95
149.53
148.93
141.91
145.40
139.92
122.14
115.07
PBT
-182.23
-411.99
-196.68
-300.32
-282.96
-247.15
289.47
575.34
840.84
1,776.17
994.96
Tax
-138.38
227.25
-153.29
-83.66
25.70
-21.11
37.88
162.65
47.88
258.21
221.74
Tax Rate
75.94%
24.81%
77.94%
27.86%
-4.01%
8.54%
13.09%
28.27%
5.38%
14.05%
42.54%
PAT
-43.85
686.06
-69.22
-194.53
-608.30
-195.72
250.08
404.91
840.72
1,579.48
299.45
PAT before Minority Interest
-56.73
688.60
-43.39
-216.66
-666.85
-226.04
251.59
412.69
842.79
1,579.48
299.45
Minority Interest
-12.88
-2.54
-25.83
22.13
58.55
30.32
-1.51
-7.78
-2.07
0.00
0.00
PAT Margin
-1.41%
24.84%
-2.08%
-4.68%
-15.45%
-4.88%
5.62%
9.04%
17.40%
28.16%
6.88%
PAT Growth
0.00%
-
-
-
-
-
-38.24%
-51.84%
-46.77%
427.46%
 
EPS
-3.96
61.92
-6.25
-17.56
-54.90
-17.66
22.57
36.54
75.88
142.55
27.03

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
3,376.76
2,671.67
2,674.80
2,852.15
3,336.71
3,775.12
3,715.35
3,581.47
2,704.18
1,471.02
Share Capital
55.39
55.37
55.34
55.32
55.27
55.25
353.59
353.43
353.34
816.09
Total Reserves
3,293.85
2,586.33
2,587.19
2,760.11
3,244.43
3,691.22
3,315.65
3,182.73
2,319.30
644.73
Non-Current Liabilities
496.72
1,194.85
1,702.75
2,088.89
3,151.38
1,893.49
1,872.46
1,161.18
1,520.80
2,891.88
Secured Loans
500.19
1,237.44
1,653.25
2,167.84
2,887.11
1,647.34
1,180.25
1,096.27
1,467.51
2,697.34
Unsecured Loans
2.66
3.46
238.22
5.27
303.16
273.26
4.59
6.03
7.64
9.05
Long Term Provisions
84.37
45.60
53.48
64.89
94.23
70.74
635.05
51.98
69.85
84.49
Current Liabilities
3,118.22
3,497.18
2,863.66
2,691.71
1,978.81
1,841.85
1,772.97
1,743.20
1,773.48
1,890.94
Trade Payables
577.97
895.27
840.24
601.78
533.81
637.69
552.56
557.79
634.15
540.80
Other Current Liabilities
1,345.49
1,579.80
1,353.09
1,548.13
690.13
621.23
844.44
947.70
789.96
978.38
Short Term Borrowings
1,066.11
903.86
561.71
437.09
662.80
550.03
348.28
210.20
182.00
260.80
Short Term Provisions
128.65
118.25
108.62
104.71
92.07
32.90
27.69
27.51
167.37
110.96
Total Liabilities
7,375.19
7,749.49
7,571.04
7,978.48
8,848.84
7,975.79
7,504.73
6,622.02
5,998.46
6,253.84
Net Block
3,343.12
3,502.29
3,057.93
2,887.96
2,772.55
2,808.70
2,122.74
2,294.63
1,989.60
2,571.34
Gross Block
5,655.58
6,703.28
6,112.89
5,772.29
5,456.40
4,377.01
4,552.96
4,642.81
4,295.75
4,211.60
Accumulated Depreciation
2,312.46
3,200.99
3,054.96
2,884.33
2,683.85
1,568.31
2,430.22
2,348.18
1,684.94
1,306.76
Non Current Assets
4,950.81
5,319.66
4,756.39
4,598.88
4,313.57
4,023.94
3,983.17
3,266.10
2,671.53
3,772.33
Capital Work in Progress
1,378.94
1,584.53
1,445.48
1,432.57
1,243.95
1,036.05
1,007.30
707.53
490.94
902.29
Non Current Investment
0.45
0.45
0.45
0.45
0.45
0.45
2.62
2.62
2.63
90.75
Long Term Loans & Adv.
227.36
230.63
252.37
277.90
296.62
178.74
845.68
235.86
183.35
207.95
Other Non Current Assets
0.94
1.76
0.16
0.00
0.00
0.00
4.83
25.46
5.01
0.00
Current Assets
2,424.38
2,429.83
2,814.65
3,379.60
4,535.27
3,951.85
3,521.56
3,355.92
3,326.93
2,481.51
Current Investments
0.00
0.00
0.00
213.25
562.27
0.00
338.72
573.98
0.00
0.00
Inventories
798.88
689.83
819.36
855.71
1,107.95
1,102.16
1,020.78
992.89
1,058.83
888.56
Sundry Debtors
917.65
1,242.69
1,273.90
962.45
1,034.45
1,111.42
741.43
481.04
958.46
758.69
Cash & Bank
291.79
268.46
448.65
1,082.25
1,603.61
1,478.11
1,234.55
1,125.80
1,096.06
699.99
Other Current Assets
416.06
56.64
20.18
8.31
226.99
260.16
186.08
182.21
213.58
134.27
Short Term Loans & Adv.
271.77
172.21
252.56
257.63
197.75
260.16
186.08
182.21
213.58
134.27
Net Current Assets
-693.84
-1,067.35
-49.01
687.89
2,556.46
2,110.00
1,748.59
1,612.72
1,553.45
590.57
Total Assets
7,375.19
7,749.49
7,571.04
7,978.48
8,848.84
7,975.79
7,504.73
6,622.02
5,998.46
6,253.84

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
-287.32
648.96
183.32
68.44
-269.47
71.61
354.96
1,476.29
1,532.40
1,343.83
PBT
915.85
-196.68
-300.32
-641.15
-247.15
357.01
575.34
890.67
1,860.20
576.72
Adjustment
-942.27
483.23
444.52
448.78
303.04
201.29
285.63
133.53
273.31
917.59
Changes in Working Capital
-143.59
379.58
80.29
278.33
-297.39
-402.76
-344.62
587.99
-266.99
-129.94
Cash after chg. in Working capital
-170.01
666.13
224.49
85.96
-241.50
155.54
516.35
1,612.19
1,866.52
1,364.37
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-117.31
-17.17
-41.17
-17.52
-27.97
-83.93
-161.39
-135.90
-334.12
-20.54
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
1,470.10
-155.53
94.57
630.24
-686.64
-818.19
-206.63
-851.62
1,085.37
-305.45
Net Fixed Assets
-199.82
-499.84
-39.00
-45.55
-166.75
-368.17
-299.87
-283.99
174.15
-181.64
Net Investments
0.00
0.00
-0.05
0.00
0.00
0.00
10.73
0.00
0.00
0.00
Others
1,669.92
344.31
133.62
675.79
-519.89
-450.02
82.51
-567.63
911.22
-123.81
Cash from Financing Activity
-1,170.82
-679.58
-776.45
-769.47
1,254.49
254.26
-75.65
-601.32
-2,245.75
-826.56
Net Cash Inflow / Outflow
11.96
-186.15
-498.56
-70.79
298.38
-492.32
72.68
23.35
372.02
211.82
Opening Cash & Equivalents
219.34
397.34
897.24
963.64
662.98
1,158.69
1,101.65
1,050.01
689.66
470.10
Closing Cash & Equivalent
232.25
219.34
397.34
897.24
963.64
664.64
1,158.69
1,101.65
1,050.01
689.66

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
302.33
238.55
238.75
254.47
298.51
339.05
306.20
294.97
216.65
63.91
ROA
9.11%
-0.57%
-2.79%
-7.93%
-2.69%
3.25%
6.09%
13.36%
25.78%
4.97%
ROE
22.99%
-1.64%
-7.94%
-21.81%
-6.42%
7.07%
12.49%
30.04%
102.78%
66.74%
ROCE
20.10%
1.32%
-0.56%
-5.47%
-0.31%
6.87%
11.25%
18.98%
43.10%
17.39%
Fixed Asset Turnover
0.45
0.52
0.70
0.70
0.82
1.00
0.98
1.08
1.32
1.05
Receivable days
142.74
138.12
98.15
92.57
97.55
75.93
49.71
54.33
55.81
57.17
Inventory Days
98.37
82.83
73.51
91.03
100.47
87.00
81.88
77.43
63.29
67.16
Payable days
99.63
129.66
86.65
67.29
64.08
64.54
63.71
65.00
65.49
65.74
Cash Conversion Cycle
141.48
91.29
85.01
116.31
133.94
98.39
67.88
66.75
53.61
58.58
Total Debt/Equity
0.70
1.22
1.28
1.33
1.26
0.71
0.55
0.54
0.77
2.25
Interest Cover
4.68
0.29
-0.13
-1.51
-0.10
3.24
11.42
11.69
9.53
2.94

News Update:


  • Wockhardt reports multi fold rise in Q2 consolidated net profit
    8th Nov 2021, 15:37 PM

    Total income of the company increased by 18.75% at Rs 867.20 crore for Q2FY22

    Read More
  • Wockhardt - Quarterly Results
    8th Nov 2021, 13:42 PM

    Read More
  • Wockhardt raises Rs 50 crore via NCDs
    22nd Oct 2021, 10:00 AM

    The Credit Facilities Committee of the Board of Directors of the company, at its meeting held on October 21, 2021, has allotted the same.

    Read More
  • Wockhardt’s arm enters into partnership with Jemincare
    26th Aug 2021, 09:32 AM

    Jemincare will be responsible for exclusive development and commercialization of the Nafithromycin in the select markets

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.